Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Axicabtagene-ciloleucel/dexamethasone

Immune effector cell-associated neurotoxicity syndrome, cytokine release syndrome and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Pensato U, et al. Case report: Reversible punctate inflammatory foci in the corpus callosum: A novel radiological finding of CAR T-cell therapy-related neurotoxicity. Frontiers in Neurology 14: 7 Feb 2023. Available from: URL: http://www.frontiersin.org/Neurology Pensato U, et al. Case report: Reversible punctate inflammatory foci in the corpus callosum: A novel radiological finding of CAR T-cell therapy-related neurotoxicity. Frontiers in Neurology 14: 7 Feb 2023. Available from: URL: http://​www.​frontiersin.​org/​Neurology
Metadaten
Titel
Axicabtagene-ciloleucel/dexamethasone
Immune effector cell-associated neurotoxicity syndrome, cytokine release syndrome and lack of efficacy: case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-40910-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Tozinameran

Case report

Multiple drugs

Case report

Atropine